What is Alzamend Neuro, Inc. Common Stock's Market Cap?

Alzamend Neuro, Inc. Common Stock's Market Cap is $5.5M, based on as-reported figures from SEC (XBRL) filings.

What is Alzamend Neuro, Inc. Common Stock's Enterprise Value?

Alzamend Neuro, Inc. Common Stock's Enterprise Value is -$2.1M, based on as-reported figures from SEC (XBRL) filings.

What is Alzamend Neuro, Inc. Common Stock's EV / EBITDA?

Alzamend Neuro, Inc. Common Stock's EV / EBITDA is 0.2×, based on as-reported figures from SEC (XBRL) filings.

What is Alzamend Neuro, Inc. Common Stock's Net Income (TTM)?

Alzamend Neuro, Inc. Common Stock's Net Income (TTM) is -$9.1M, based on as-reported figures from SEC (XBRL) filings.

What is Alzamend Neuro, Inc. Common Stock's EBITDA?

Alzamend Neuro, Inc. Common Stock's EBITDA is -$9.0M, based on as-reported figures from SEC (XBRL) filings.

What is Alzamend Neuro, Inc. Common Stock's Diluted EPS (TTM)?

Alzamend Neuro, Inc. Common Stock's Diluted EPS (TTM) is -1.89, based on as-reported figures from SEC (XBRL) filings.

What is Alzamend Neuro, Inc. Common Stock's Net Debt?

Alzamend Neuro, Inc. Common Stock's Net Debt is -$7.6M, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / PHARMACEUTICAL PREPARATIONS

Alzamend Neuro, Inc. Common Stock

XNAS · usd

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00ZMXG7N7

1.13▲ 0.01 (0.89%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E: —
Price / Sales: —
EV / Revenue: —
EV / EBITDA

Financial Highlights

Revenue (TTM): —
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin: —
Net Debt

Trading Information

Previous Close: 1.12
Day's Range: 1.10 – 1.19
52-Week Range: 0.84 – 2.68
Volume: 29.0K
Avg Volume: 68.4K

Share Statistics

Shares Outstanding
Employees: 7
Exchange: XNAS
Listed: 2021-06-15

Share count as of September 10, 2026

Alzamend Neuro, Inc. Common Stock (ALZN) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Alzamend Neuro, Inc. Common Stock (ALZN)

What is Alzamend Neuro, Inc. Common Stock's Market Cap?: Alzamend Neuro, Inc. Common Stock's Market Cap is $5.5M, based on as-reported figures from SEC (XBRL) filings.
What is Alzamend Neuro, Inc. Common Stock's Enterprise Value?: Alzamend Neuro, Inc. Common Stock's Enterprise Value is -$2.1M, based on as-reported figures from SEC (XBRL) filings.
What is Alzamend Neuro, Inc. Common Stock's EV / EBITDA?: Alzamend Neuro, Inc. Common Stock's EV / EBITDA is 0.2×, based on as-reported figures from SEC (XBRL) filings.
What is Alzamend Neuro, Inc. Common Stock's Net Income (TTM)?: Alzamend Neuro, Inc. Common Stock's Net Income (TTM) is -$9.1M, based on as-reported figures from SEC (XBRL) filings.
What is Alzamend Neuro, Inc. Common Stock's EBITDA?: Alzamend Neuro, Inc. Common Stock's EBITDA is -$9.0M, based on as-reported figures from SEC (XBRL) filings.
What is Alzamend Neuro, Inc. Common Stock's Diluted EPS (TTM)?: Alzamend Neuro, Inc. Common Stock's Diluted EPS (TTM) is -1.89, based on as-reported figures from SEC (XBRL) filings.
What is Alzamend Neuro, Inc. Common Stock's Net Debt?: Alzamend Neuro, Inc. Common Stock's Net Debt is -$7.6M, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · ALZNAs-filed SEC (XBRL) data